Centene CFO to step down at year end
Chris Neczypor, the finance chief at Lincoln Financial, will succeed Drew Asher on Jan. 1. Asher plans to retire at the end of 2027.
Uncategorized
Investor suit says UnitedHealth ignored governance, cybersecurity gaps for years
UnitedHealth misled investors, shuttered an internal Medicare billing audit and ignored cybersecurity lapses that led to the historic Change Healthcare cyberattack, according to a lawsuit filed by two shareholder groups.
Investor suit says UnitedHealth ignored governance, cybersecurity gaps for years Read More »
J&J’s Monarch robot wins FDA nod for AI features
The lung bronchoscopy robot adds improvements that include new tools for pre-procedure planning and updated navigation and visual guidance during the procedure.
J&J’s Monarch robot wins FDA nod for AI features Read More »
FDA names second participant in TEMPO digital health pilot
Cadence, a company that makes AI-enabled software to support hypertension management, will join the pilot, which allows companies to collect real-world data through Medicare.
FDA names second participant in TEMPO digital health pilot Read More »
EyePoint’s Phase 3 fail sends stock spiraling amid next-gen AMD race
EyePoint’s quest to reduce treatment burden for patients with age-related macular degeneration has hit a bump in the road, with a clinical miss driving the biotech’s stock down by 70%.
EyePoint’s Phase 3 fail sends stock spiraling amid next-gen AMD race Read More »
Summit, Akeso’s China approval celebration cut short as survival benefit degrades
Ivonescimab notched its third approval in China last week, but the label update has tempered expectations for the Summit Therapeutics/Akeso drug, showing that progression-free survival declines over time.
Summit, Akeso’s China approval celebration cut short as survival benefit degrades Read More »
AstraZeneca pulls plug on late-stage lung cancer trial, extending losing streak
AstraZeneca will push through with its other Phase 3 studies for volrustomig, including in cervical cancer and mesothelioma.
AstraZeneca pulls plug on late-stage lung cancer trial, extending losing streak Read More »
Escaneado 3D e inteligencia artificial: la revolución silenciosa de la ortodoncia
La transformación digital también ha llegado a la odontología. Uno de los ámbitos donde más se aprecia esta evolución es la ortodoncia, que en los últimos años ha incorporado herramientas capaces de mejorar la precisión de los …
Escaneado 3D e inteligencia artificial: la revolución silenciosa de la ortodoncia Read More »
J&J hands lymphoma bispecific CAR T back to AbelZeta
Johnson & Johnson secured rights to prizlon-cel in 2023 for $245 million upfront. The asset in June last year showed a 100% response rate as a second-line option in a Phase 1b study for 10 patients with relapsed or refractory large B cell lymphoma.
J&J hands lymphoma bispecific CAR T back to AbelZeta Read More »
Vera’s newly approved IgA nephropathy drug supports kidney function, like Otsuka’s Voyxact
Otsuka Pharmaceuticals’ Voyxact is not the only IgA nephropathy drug that can slow the decline of kidney function. Vera Therapeutics’ Trutakna, which the FDA granted accelerated approval last month, showed “impressive” stabilization, analysts say.